Silvia Egert

551 total citations
15 papers, 379 citations indexed

About

Silvia Egert is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Silvia Egert has authored 15 papers receiving a total of 379 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Cardiology and Cardiovascular Medicine and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Silvia Egert's work include Metabolism, Diabetes, and Cancer (4 papers), Cardiovascular Function and Risk Factors (3 papers) and Dementia and Cognitive Impairment Research (2 papers). Silvia Egert is often cited by papers focused on Metabolism, Diabetes, and Cancer (4 papers), Cardiovascular Function and Risk Factors (3 papers) and Dementia and Cognitive Impairment Research (2 papers). Silvia Egert collaborates with scholars based in Germany, United States and Czechia. Silvia Egert's co-authors include Markus Schwaiger, Ngoc Nguyen, Stefan Wagenpfeil, Alexander Kurz, Katja Werheid, Lutz Frölich, Angelika Thöne-Otto, Hermann‐Josef Gertz, Victoria Kehl and Daqing Sun and has published in prestigious journals such as Journal of the American College of Cardiology, Circulation Research and Cancer Research.

In The Last Decade

Silvia Egert

15 papers receiving 358 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Silvia Egert Germany	8	132	102	95	81	47	15	379
Haibo Wu China	13	80 0.6×	122 1.2×	29 0.3×	71 0.9×	39 0.8×	43	437
Jordi Sanahuja Spain	13	119 0.9×	75 0.7×	49 0.5×	50 0.6×	95 2.0×	35	630
Masayo Ogawa Japan	14	57 0.4×	60 0.6×	111 1.2×	27 0.3×	66 1.4×	31	394
Marina Titlić Croatia	13	68 0.5×	26 0.3×	82 0.9×	77 1.0×	17 0.4×	75	524
Young Hoon Kim South Korea	13	103 0.8×	26 0.3×	133 1.4×	41 0.5×	14 0.3×	26	521
Adithya Balasubramanian United States	16	134 1.0×	28 0.3×	52 0.5×	106 1.3×	18 0.4×	65	602
Yasuko Tatewaki Japan	13	60 0.5×	30 0.3×	36 0.4×	41 0.5×	98 2.1×	52	427
Jordi Gich Spain	10	89 0.7×	30 0.3×	92 1.0×	55 0.7×	14 0.3×	21	436
G. Désaméricq France	9	49 0.4×	243 2.4×	88 0.9×	48 0.6×	26 0.6×	15	444
Roque Villagra Chile	9	52 0.4×	139 1.4×	69 0.7×	60 0.7×	56 1.2×	23	467

Countries citing papers authored by Silvia Egert

Since Specialization

Citations

This map shows the geographic impact of Silvia Egert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Silvia Egert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Silvia Egert more than expected).

Fields of papers citing papers by Silvia Egert

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Silvia Egert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Silvia Egert. The network helps show where Silvia Egert may publish in the future.

Co-authorship network of co-authors of Silvia Egert

This figure shows the co-authorship network connecting the top 25 collaborators of Silvia Egert. A scholar is included among the top collaborators of Silvia Egert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Silvia Egert. Silvia Egert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Bronger, Holger, Silvia Egert, Peter A. Fasching, et al.. (2021). Abstract OT-26-01: ABEMACARE: Abemaciclib in combination with endocrine therapy as first line therapy in metastatic breast cancer patients with symptomatic visceral metastases or high tumor burden. Cancer Research. 81(4_Supplement). OT–26. 1 indexed citations

Padberg, Frank, Ulrike Kumpf, Ulrich Mansmann, et al.. (2017). Prefrontal transcranial direct current stimulation (tDCS) as treatment for major depression: study design and methodology of a multicenter triple blind randomized placebo controlled trial (DepressionDC). European Archives of Psychiatry and Clinical Neuroscience. 267(8). 751–766. 28 indexed citations

Schlesinger‐Raab, Anne, André L. Mihaljević, Silvia Egert, et al.. (2015). Outcome of gastric cancer in the elderly: a population-based evaluation of the Munich Cancer Registry. Gastric Cancer. 19(3). 713–722. 31 indexed citations

Schlesinger‐Raab, Anne, André L. Mihaljević, Silvia Egert, et al.. (2014). Level of hospital care and outcome of gastric cancer: a population-based evaluation of the Munich Cancer Registry. Journal of Cancer Research and Clinical Oncology. 140(5). 789–800. 3 indexed citations

Günter, C. I., et al.. (2013). Erythropoetin in der Plastischen Chirurgie. Handchirurgie · Mikrochirurgie · Plastische Chirurgie. 45(4). 252–252. 1 indexed citations

Günter, C. I., et al.. (2013). Erythropoetin in der Plastischen Chirurgie. Handchirurgie · Mikrochirurgie · Plastische Chirurgie. 45(2). 108–119. 2 indexed citations

Kurz, Alexander, Angelika Thöne-Otto, Silvia Egert, et al.. (2011). CORDIAL. Alzheimer Disease & Associated Disorders. 26(3). 246–253. 87 indexed citations

Kurz, Alexander, Silvia Egert, Lutz Frölich, et al.. (2008). Neuropsychologisch fundierte kognitive Verhaltenstherapie für Patienten mit Alzheimer-Krankheit im Frühstadium. 21(3). 157–161. 2 indexed citations

Egert, Silvia, Stefan Wagenpfeil, & Hans Förstl. (2007). Cholinesterase-Inhibitoren und Alzheimer-Demenz: Metaanalyse zu Wirksamkeitsnachweis, Ursprung und Ergebnisverzerrung in publizierten Studien. DMW - Deutsche Medizinische Wochenschrift. 132(22). 1207–1213. 5 indexed citations

10.

Egert, Silvia, et al.. (2007). Characterization of a Peptide that Specifically Blocks the Ras Binding Domain of p75. International Journal of Peptide Research and Therapeutics. 13(3). 413–421. 1 indexed citations

11.

Simões, Marcus Vinícius, Silvia Egert, Sibylle Ziegler, et al.. (2004). Delayed response of insulin-stimulated fluorine-18 deoxyglucose uptake in glucose transporter-4-null mice hearts. Journal of the American College of Cardiology. 43(9). 1690–1697. 11 indexed citations

12.

Egert, Silvia, Ngoc Nguyen, & Markus Schwaiger. (1999). Myocardial Glucose Transporter GLUT1: Translocation Induced by Insulin and Ischemia. Journal of Molecular and Cellular Cardiology. 31(7). 1337–1344. 53 indexed citations

13.

Egert, Silvia, Ngoc Nguyen, & Markus Schwaiger. (1999). Contribution of α-Adrenergic and β-Adrenergic Stimulation to Ischemia-Induced Glucose Transporter (GLUT) 4 and GLUT1 Translocation in the Isolated Perfused Rat Heart. Circulation Research. 84(12). 1407–1415. 55 indexed citations

14.

Egert, Silvia. (1997). Effects of wortmannin on insulin- and ischemia-induced stimulation of GLUT4 translocation and FDG uptake in perfused rat hearts. Cardiovascular Research. 35(2). 283–293. 66 indexed citations

15.

Brosius, Frank C., Ngoc Nguyen, Silvia Egert, et al.. (1997). Increased Sarcolemmal Glucose Transporter Abundance in Myocardial Ischemia. The American Journal of Cardiology. 80(3). 77A–84A. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact